**Controversies in Polycystic Ovary Syndrome** Provisional chapter

DOI: 10.5772/intechopen.72513

Controversies in Polycystic Ovary Syndrome

Işık Kaban, Filiz Cebeci, Melek Aslan Kayıran and

Vefa Asli Erdemir

Additional information is available at the end of the chapter Işık Kaban, Filiz Cebeci, Melek Aslan Kayıran and Vefa Asli Erdemir

http://dx.doi.org/10.5772/intechopen.72513 Additional information is available at the end of the chapter

#### Abstract

Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy that affects women from puberty to whole reproductive life. Diagnosis and treatment of PCOS is not clear. Polycystic ovary syndrome is a multisystem disease that involves dermatologist examining patients with clinical hyperandrogenism and/or biochemical signs of hyperandrogenism; gynecologist examines patients with oligo-ovulation or infertility. The management of PCOS should be tailored to each woman's specific symptoms, fertility-related implications, and metabolic disorders. Pharmacologic treatment is not necessary for all patients with PCOS, also lifestyle changes like exercise, weight loss, and diet are effective for treatment. Lifestyle changes are often recommended as first-line treatment for PCOS to benefit general health. Topical nonhormonal therapies and laser hair removal may be effective for cutaneous symptoms like acne, hirsutism, and androgenetic alopecia in the PCOS population and are useful first-line agents. Some pharmacological agents (anti-androgens) are used to control the dermatological symptoms of hyperandrogenism. Metformin is useful for metabolic and glycemic anomalies and for the treatment of menstrual irregularities, but less effective than antiandrogens for the treatment of both hirsutism and acne. The aim of this study is to talk about unclear topics in PCOS and multidisciplinary approach to patients.

Keywords: polycystic ovarian syndrome, hyperandrogenism amenorrhea, hirsutism, infertility
